Inflammatory diseases influence tissue metabolism, altering regulation of extracellular
adenine nucleotides, with a resultant protective influence of
adenosine.
Ecto-5'-nucleotidase (CD73) is a central surface
enzyme generating extracellular
adenosine. Thus, we hypothesized that CD73 is protective in mucosal
inflammation as modeled by
trinitrobenzene sulfonate (TNBS)
colitis. Initial studies revealed a >3-fold induction of CD73
mRNA levels after TNBS
colitis. Additionally, the severity of
colitis was increased, as determined by
weight loss and colonic shortening, in cd73(-/-) mice relative to cd73(+/+) controls. Likewise, enteral administration of the selective CD73 inhibitor
alpha,beta-methylene ADP to cd73(+/+) mice resulted in a similar increase in severity of TNBS
colitis. Gene array profiling of
cytokine mRNA expression, verified by real-time PCR, revealed a >90% down-regulation of IFN-alphaA in cd73(-/-) mice and
alpha,beta-methylene ADP-treated cd73(+/+) mice, compared with cd73(+/+) mice. Exogenous administration of recombinant IFN-alphaA partially protected TNBS-treated cd73(-/-) mice.
Cytokine profiling revealed similar increases in both IFN-gamma and
TNF-alpha mRNA in colitic animals, independent of genotype. However,
IL-10 mRNA increased in wild-type mice on day 3 after TNBS administration, whereas cd73(-/-) mice mounted no
IL-10 response. This
IL-10 response was restored in the cd73(-/-) mice by exogenous IFN-alphaA. Further
cytokine profiling revealed that this
IL-10 induction is preceded by a transient IFN-alphaA induction on day 2 after TNBS exposure. Together, these studies indicate a critical regulatory role for CD73-modulated IFNalphaA in the acute inflammatory phase of TNBS
colitis, thereby implicating IFN-alphaA as a protective
element of
adenosine signaling during mucosal
inflammation.